Rebecca Dobson

1.7k total citations
41 papers, 986 citations indexed

About

Rebecca Dobson is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Epidemiology. According to data from OpenAlex, Rebecca Dobson has authored 41 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 13 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Rebecca Dobson's work include Neuroendocrine Tumor Research Advances (10 papers), Neuroblastoma Research and Treatments (10 papers) and Chemotherapy-induced cardiotoxicity and mitigation (10 papers). Rebecca Dobson is often cited by papers focused on Neuroendocrine Tumor Research Advances (10 papers), Neuroblastoma Research and Treatments (10 papers) and Chemotherapy-induced cardiotoxicity and mitigation (10 papers). Rebecca Dobson collaborates with scholars based in United Kingdom, United States and Denmark. Rebecca Dobson's co-authors include Daniel J. Cuthbertson, Malcolm I. Burgess, Victoria S. Sprung, Juan W. Valle, Graham J. Kemp, A. Margot Umpleby, David J. Wright, Christos Toumpanakis, Helen Jones and Simona Grozinsky‐Glasberg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Rebecca Dobson

37 papers receiving 950 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca Dobson United Kingdom 16 587 392 384 161 141 41 986
Julie Dang United States 16 198 0.3× 76 0.2× 224 0.6× 26 0.2× 21 0.1× 38 1.2k
Wayne Frederick United States 19 121 0.2× 75 0.2× 593 1.5× 42 0.3× 49 0.3× 48 1.4k
Ignacio Ferreira González Spain 20 90 0.2× 121 0.3× 179 0.5× 30 0.2× 86 0.6× 61 1.2k
Patricia Stephenson United States 21 92 0.2× 72 0.2× 693 1.8× 49 0.3× 44 0.3× 48 1.8k
Melanie L. Richards United States 30 293 0.5× 154 0.4× 307 0.8× 1.2k 7.3× 64 0.5× 58 2.2k
Rabia Shahid Canada 12 175 0.3× 31 0.1× 247 0.6× 72 0.4× 50 0.4× 26 926
Shibao Feng United States 20 336 0.6× 18 0.0× 948 2.5× 166 1.0× 96 0.7× 52 1.9k
Susan Moran United States 17 96 0.2× 128 0.3× 330 0.9× 32 0.2× 29 0.2× 58 1.5k
Victoria J. Sinibaldi United States 23 80 0.1× 43 0.1× 843 2.2× 224 1.4× 40 0.3× 57 2.0k
A. Verdecchia Italy 16 304 0.5× 28 0.1× 922 2.4× 34 0.2× 53 0.4× 31 1.9k

Countries citing papers authored by Rebecca Dobson

Since Specialization
Citations

This map shows the geographic impact of Rebecca Dobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Dobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Dobson more than expected).

Fields of papers citing papers by Rebecca Dobson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Dobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Dobson. The network helps show where Rebecca Dobson may publish in the future.

Co-authorship network of co-authors of Rebecca Dobson

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Dobson. A scholar is included among the top collaborators of Rebecca Dobson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Dobson. Rebecca Dobson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Gent, David, Muhammad Wasif Saif, Rebecca Dobson, & David J. Wright. (2024). Cardiovascular Disease After Hematopoietic Stem Cell Transplantation in Adults. JACC CardioOncology. 6(4). 475–495. 4 indexed citations
4.
Adeniji, Johnson Adekunle, et al.. (2023). 2183P The relevance of HFpEF in immunotherapy-induced myocarditis: An analysis of 65 patients. Annals of Oncology. 34. S1131–S1131. 1 indexed citations
5.
Gent, David & Rebecca Dobson. (2023). The 2022 European Society of Cardiology Cardio-oncology Guidelines in Focus. European Cardiology Review. 18. e16–e16. 15 indexed citations
6.
Grozinsky‐Glasberg, Simona, Joseph Davar, Johannes Hofland, et al.. (2022). European Neuroendocrine Tumor Society ( ENETS ) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease. Journal of Neuroendocrinology. 34(7). e13146–e13146. 76 indexed citations
7.
Gent, David, Nasim Ali, Anna Olsson‐Brown, et al.. (2022). Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights. SHILAP Revista de lepidopterología. 15(3). 950–959. 2 indexed citations
8.
Gent, David, Muhammad Wasif Saif, Jungwha Lee, et al.. (2022). Cardiovascular screening prior to stem cell transplantation in the United Kingdom. SHILAP Revista de lepidopterología. 3(4). 1455–1458. 3 indexed citations
9.
Lagan, Jakub, Josephine H. Naish, Christopher S. Campbell, et al.. (2022). Acute and Chronic Cardiopulmonary Effects of High Dose Interleukin-2 Therapy: An Observational Magnetic Resonance Imaging Study. Diagnostics. 12(6). 1352–1352. 1 indexed citations
10.
Wright, David J., et al.. (2021). Chemotherapy-Induced Arrhythmia – Underrecognized and Undertreated. The American Journal of Medicine. 134(10). 1224–1231.e1. 12 indexed citations
11.
Dobson, Rebecca, et al.. (2021). How to Manage Atrial Fibrillation Secondary to Ibrutinib. JACC CardioOncology. 3(1). 140–144. 16 indexed citations
12.
Walker, John M., et al.. (2020). Cardio-oncology for the general physician: ‘old’ and ‘new’ cardiovascular toxicities and how to manage them. British Journal of Hospital Medicine. 81(9). 1–11. 2 indexed citations
13.
Dobson, Rebecca & David J. Wright. (2018). Management of cardiac implantable devices in patients undergoing radiotherapy. Current Problems in Cancer. 42(4). 443–448. 3 indexed citations
14.
Davar, Joseph, Heidi M. Connolly, Martyn Caplin, et al.. (2017). Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors. Journal of the American College of Cardiology. 69(10). 1288–1304. 155 indexed citations
15.
Dobson, Rebecca, Juan W. Valle, Malcolm I. Burgess, G.J. Poston, & Daniel J. Cuthbertson. (2015). Variation in Cardiac Screening and Management of Carcinoid Heart Disease in the UK and Republic of Ireland. Clinical Oncology. 27(12). 741–746. 15 indexed citations
16.
Lundy, Mark W., Shuxin Sun, Xiaonan Duan, et al.. (2014). Skeletal Retention and Urinary Excretion of Nitrogen-Containing Bisphosphonates Including Fluorescently-labeled Bisphosphonates in Rats.. Journal of Bone and Mineral Research. 29. 1 indexed citations
17.
Dobson, Rebecca, Malcolm I. Burgess, Melissa Banks, et al.. (2013). The Association of a Panel of Biomarkers with the Presence and Severity of Carcinoid Heart Disease: A Cross-Sectional Study. PLoS ONE. 8(9). e73679–e73679. 52 indexed citations
18.
Dobson, Rebecca, Daniel J. Cuthbertson, & Malcolm I. Burgess. (2013). The optimal use of cardiac imaging in the quantification of carcinoid heart disease. Endocrine Related Cancer. 20(5). R247–R255. 9 indexed citations
19.
Dobson, Rebecca, Sobhan Vinjamuri, James Hsuan, et al.. (2013). Treatment of Orbital Metastases From a Primary Midgut Neuroendocrine Tumor With Peptide-Receptor Radiolabeled Therapy Using 177Lutetium-DOTATATE. Journal of Clinical Oncology. 31(17). e272–e275. 10 indexed citations
20.
Dobson, Rebecca. (2007). General practice for foundation doctors: an easy option?. PubMed. 57(537). 331–331.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Dang Breakdown of academic impact, for papers by Wayne Frederick Breakdown of academic impact, for papers by Ignacio Ferreira González Breakdown of academic impact, for papers by Patricia Stephenson Breakdown of academic impact, for papers by Melanie L. Richards Breakdown of academic impact, for papers by Rabia Shahid Breakdown of academic impact, for papers by Shibao Feng Breakdown of academic impact, for papers by Susan Moran Breakdown of academic impact, for papers by Victoria J. Sinibaldi Breakdown of academic impact, for papers by A. Verdecchia
Rankless by CCL
2026